Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Share Price
Equities
ANGEN
TREANGN00028
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.28 TRY | -1.12% | -5.41% | +6.67% |
Sales 2021 | 410M 12.64M 1.01B | Sales 2022 | 269M 8.28M 663M | Capitalization | 4.74B 146M 11.68B |
---|---|---|---|---|---|
Net income 2021 | 433M 13.34M 1.07B | Net income 2022 | 330M 10.17M 813M | EV / Sales 2021 | 6.59 x |
Net cash position 2021 | 511M 15.73M 1.26B | Net cash position 2022 | 411M 12.67M 1.01B | EV / Sales 2022 | 16.1 x |
P/E ratio 2021 |
5.1
x | P/E ratio 2022 |
14.3
x | Employees | 171 |
Yield 2021 * |
-
| Yield 2022 |
2.76% | Free-Float | 25.33% |
1 day | -1.12% | ||
1 week | -5.41% | ||
Current month | +5.90% | ||
1 month | +5.90% | ||
3 months | -1.92% | ||
6 months | -5.21% | ||
Current year | +6.67% |
Managers | Title | Age | Since |
---|---|---|---|
Elif Akyuz
FOU | Founder | 49 | 10/06/10 |
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10/06/10 |
Director of Finance/CFO | 37 | 30/11/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10/06/10 |
Elif Akyuz
FOU | Founder | 49 | 10/06/10 |
Director of Finance/CFO | 37 | 30/11/20 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 13.28 | -1.12% | 1,732,555 |
29/04/24 | 13.43 | -4.00% | 2,351,359 |
26/04/24 | 13.99 | -1.20% | 1,528,647 |
25/04/24 | 14.16 | +0.93% | 3,021,144 |
24/04/24 | 14.03 | -0.07% | 2,699,917 |
Delayed Quote Borsa Istanbul, April 30, 2024 at 04:08 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+6.67% | 90.18M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ANGEN Stock